Ordinary Share Capital Cambiamento Data
Abbott USD 25.02B 408M 2024-09
Amgen USD 33.53B 140M 2024-12
Ardelyx USD 24K 0 2024-12
Corcept Therapeutics USD 136K 1000 2024-12
Life Technologies USD 76K 0 2024-09
TG Therapeutics USD 156K 0 2024-12
United Therapeutics USD 800K 100K 2024-12



Ardelyx Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.